Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems

Background: To reduce colorectal cancer mortality, positive fecal blood tests must be followed by colonoscopy. Methods: We identified 62,384 individuals ages 50 to 89 years with a positive fecal blood test between January 1, 2011 and December 31, 2012 in four health care systems within the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. We estimated the probability of follow-up colonoscopy and 95% confidence intervals (CI) using the Kaplan–Meier method. Overall differences in cumulative incidence of follow-up across health care systems were assessed with the log-rank test. HRs and 95% CIs were estimated from multivariate Cox proportional hazards models. Results: Most patients who received a colonoscopy did so within 6 months of their positive fecal blood test, although follow-up rates varied across health care systems (P <0.001). Median days to colonoscopy ranged from 41 (95% CI, 40–41) to 174 (95% CI, 123–343); percent followed-up by 12 months ranged from 58.1% (95% CI, 51.6%–63.7%) to 83.8% (95% CI, 83.4%–84.3%) and differences across health care systems were also observed at 1, 2, 3, and 6 months. Increasing age and comorbidity score were associated with lower follow-up rates. Conclusion: Individual characteristics and health care system were associated with colonoscopy after positive fecal blood tests. Patterns were consistent across health care systems, but proportions of patients receiving follow-up varied. These findings suggest that there is room to improve follow-up of positive colorectal cancer screening tests. Impact: Understanding the timing of colonoscopy after positive fecal blood tests and characteristics associated with lack of follow-up may inform future efforts to improve follow-up. Cancer Epidemiol Biomarkers Prev; 25(2); 344–50. ©2016 AACR.

[1]  Jasmin A. Tiro,et al.  Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium , 2016, Journal of General Internal Medicine.

[2]  Sarah E Lillie,et al.  Organizational Predictors of Colonoscopy Follow-up for Positive Fecal Occult Blood Test Results: An Observational Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[3]  S. Vernon,et al.  Results of Nurse Navigator Follow-up After Positive Colorectal Cancer Screening Test: A Randomized Trial , 2014, The Journal of the American Board of Family Medicine.

[4]  J. Zapka,et al.  Follow-up to Abnormal Cancer Screening Tests: Considering the Multilevel Context of Care , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[5]  Yingye Zheng,et al.  The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[6]  JL Krok,et al.  Clinic Type and Patient Characteristics Affecting Time to Resolution After an Abnormal Cancer-Screening Exam , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[7]  J. Le Breton,et al.  Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test , 2013, British Journal of Cancer.

[8]  Mack T. Ruffin,et al.  What is lacking in current decision aids on cancer screening? , 2013, CA: a cancer journal for clinicians.

[9]  E. Seiber,et al.  The Ohio Patient Navigation Research Program: Does the American Cancer Society Patient Navigation Model Improve Time to Resolution in Patients with Abnormal Screening Tests? , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[10]  C. von Wagner,et al.  Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme , 2012, British Journal of Cancer.

[11]  K. Choi,et al.  Adherence to follow‐up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004–2008 , 2012, Journal of gastroenterology and hepatology.

[12]  S. Bolen,et al.  Body Mass Index and Colon Cancer Screening: A Systematic Review and Meta-Analysis , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[13]  M. Helfand,et al.  Improving the Follow-Up of Positive Hemoccult Screening Tests: An Electronic Intervention , 2011, Journal of General Internal Medicine.

[14]  L. Walter,et al.  Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up? , 2011, Archives of internal medicine.

[15]  S. Ho,et al.  Improving the Effectiveness of Fecal Occult Blood Testing in a Primary Care Clinic by Direct Colonoscopy Referral for Positive Tests , 2010, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[16]  C Fraser,et al.  Effect of Gender, Age and Deprivation on Key Performance Indicators in a Fobt-based Colorectal Screening Programme , 2010, Journal of medical screening.

[17]  D. Almirall,et al.  Time from Positive Screening Fecal Occult Blood Test to Colonoscopy and Risk of Neoplasia , 2009, Digestive Diseases and Sciences.

[18]  M. Partin,et al.  Timely follow-up of positive fecal occult blood tests strategies associated with improvement. , 2009, American journal of preventive medicine.

[19]  Hardeep Singh,et al.  Using a Multifaceted Approach to Improve the Follow-Up of Positive Fecal Occult Blood Test Results , 2009, The American Journal of Gastroenterology.

[20]  Sandhya K. Rao,et al.  Challenges in the Management of Positive Fecal Occult Blood Tests , 2009, Journal of General Internal Medicine.

[21]  B. Turner,et al.  Reasons Patients With a Positive Fecal Occult Blood Test Result Do Not Undergo Complete Diagnostic Evaluation , 2009, The Annals of Family Medicine.

[22]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[23]  E. Feuer,et al.  Improvement in the Diagnostic Evaluation of a Positive Fecal Occult Blood Test in an Integrated Health Care Organization , 2008, Medical care.

[24]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[25]  Katherine S. Garman,et al.  Colorectal Cancer Screening, Comorbidity, and Follow-up in Elderly Patients , 2006, The American journal of the medical sciences.

[26]  D. Fisher,et al.  Barriers to Full Colon Evaluation for a Positive Fecal Occult Blood Test , 2006, Cancer Epidemiology Biomarkers & Prevention.

[27]  Timothy R Church,et al.  A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. , 2004, Journal of the National Cancer Institute.

[28]  Terry Hyslop,et al.  Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. , 2004, Preventive medicine.

[29]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[30]  W. Hauck,et al.  Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test , 2003, Journal of General Internal Medicine.

[31]  B. Rosner,et al.  Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood , 2001, American Journal of Gastroenterology.

[32]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[33]  L. Rabeneck,et al.  Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[34]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.